Biotalys NV (DE:86C) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Biotalys NV has secured EUR 15 million in funding through a private placement, issuing new shares to investors including Ackermans & van Haaren NV and ASR Vermogensbeheer NV. The funds will advance their AGROBODY™ technology platform and biocontrol product pipeline, including their biofungicide EVOCA™ awaiting regulatory approval. The investment is intended to support further R&D, regulatory processes, and the company’s strategic growth in sustainable crop protection.
For further insights into DE:86C stock, check out TipRanks’ Stock Analysis page.